Structures by: Saravanan S.
Total: 13
Glycine--<i>D</i>-tartaric acid (1/1)
C2H5NO2,C4H6O6
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 2 o236
a=4.8387(2)Å b=9.2913(4)Å c=20.0273(8)Å
α=90.00° β=90.1710(10)° γ=90.00°
1,2-Bis(2,4-dinitrophenoxy)ethane
C14H10N4O10
Acta Crystallographica Section E (2004) 60, 11 o2056-o2058
a=6.88760(10)Å b=13.92890(10)Å c=16.5396(5)Å
α=90.00° β=95.146(3)° γ=90.00°
4'-methoxy-4-methoxycarbonyl-2,6-dinitrostilbene
C17H14N2O7
Acta Crystallographica Section E (2004) 60, 11 o2053-o2055
a=12.0496(8)Å b=7.0295(5)Å c=19.8296(13)Å
α=90.00° β=100.8560(10)° γ=90.00°
{3-[4-(N,N-Dimethylamino)phenyl]-1-(4-methylphenyl)- 3-(phenylsulfanyl)propylidene}semicarbazide
C25H28N4OS
Acta Crystallographica Section E (2004) 60, 10 o1895-o1897
a=6.804(5)Å b=10.531(4)Å c=17.278(5)Å
α=88.96(5)° β=79.24(3)° γ=73.51(2)°
2-(1H-1,3-Benzimidazol-2-ylsulfanyl)-1-(4-methylphenyl)ethanone semicarbazone
C17H17N5OS
Acta Crystallographica Section E (2006) 62, 9 o3897-o3899
a=21.525(5)Å b=21.525(5)Å c=17.396(4)Å
α=90.00° β=90.00° γ=90.00°
4-(4-Chlorophenyl)-5-[2-methyl-1-(4-methylphenyl)-2-nitropropyl]-1,2,3- selenadiazole
C19H18ClN3O2Se
Acta Crystallographica Section E (2007) 63, 10 o4024-o4024
a=13.346(3)Å b=9.636(2)Å c=14.887(3)Å
α=90° β=95.668(4)° γ=90°
5-[2-Methyl-1-(4-methylphenyl)-2-nitropropyl]-4-phenyl-1,2,3-selenadiazole
C19H19N3O2Se
Acta Crystallographica Section E (2007) 63, 10 o4167-o4167
a=10.184(3)Å b=10.592(3)Å c=17.408(4)Å
α=90° β=101.637(4)° γ=90°
5-(2-Methyl-2-nitro-1-phenylpropyl)-4-phenyl-1,2,3-selenadiazole
C18H17N3O2Se
Acta Crystallographica Section E (2007) 63, 12 o4676-o4676
a=10.0178(8)Å b=10.2084(8)Å c=17.4139(14)Å
α=90.00° β=104.8200(10)° γ=90.00°
Diethyl 2-[(4-nitrophenyl)(4-phenyl-1,2,3-selenadiazol-5-yl)methyl]malonate
C22H21N3O6Se
Acta Crystallographica Section E (2008) 64, 4 o729
a=9.9530(6)Å b=10.5220(6)Å c=12.2305(7)Å
α=79.350(3)° β=74.632(3)° γ=67.632(3)°
4-(4-Chlorophenyl)-5-[1-(4-chlorophenyl)-2-methyl-2-nitropropyl]-1,2,3- selenadiazole
C18H15Cl2N3O2Se
Acta Crystallographica Section E (2008) 64, 2 o349-o349
a=7.8352(2)Å b=10.9208(3)Å c=11.5507(3)Å
α=75.3810(10)° β=89.0440(10)° γ=83.3310(10)°
Stilbene
C15H10N4O9
Acta Crystallographica Section C (2003) 59, 3 o156-o158
a=7.096(4)Å b=8.550(3)Å c=28.101(5)Å
α=90.00° β=90.87(3)° γ=90.00°
Ethyl (Z)-3-(4-chlorophenyl)-2-cyano-3-(4-phenyl-1,2,3-selenadiazol-5-yl)- 2-propenoate
C20H14ClN3O2Se
Journal of Organic Chemistry (2008) 73, 2323-2329
a=22.158(8)Å b=12.990(5)Å c=13.502(7)Å
α=90.00° β=102.643(5)° γ=90.00°
Ethyl 5-(4-chlorobenzoyl)-3-cyano-4-(4-chlorophenyl)-2-(4-methoxyphenyl)-1- phenyl-2,3-dihydro-1H-pyrrole-3-carboxylate
C34H27Cl2N2O4
Journal of Organic Chemistry (2008) 73, 2323-2329
a=15.2318(5)Å b=10.6472(4)Å c=19.2838(7)Å
α=90.00° β=106.9530(10)° γ=90.00°